Edition 3 / September 2020
Dr. John Cameron,
Associate Director, Sales & Key Account Management
Although CordenPharma was very much looking forward to meeting you in person at CPhI Worldwide in Milan this year, it was, like many plans….cancelled due to the Coronavirus pandemic. With two sites in the Milan area (CordenPharma Caponago for Injectables and CordenPharma Bergamo for large-scale Small Molecules manufacture), the CordenPharma Team was excited to welcome you to our Italian home, and share the pharmaceutical dolce vita with you.
Do not despair! Instead, we warmly welcome you to meet with us virtually during the dates of the CPHI Festival of Pharma (October 5th – 16th). Over this 10 day period, you will be able to book a meeting slot at a time that suits you, from the comfort of your own desk, without having to worry about which shoes to wear.
Whether you have a new or existing project to discuss with CordenPharma, Key Account Managers, Platform Directors, Project Managers and Executive Leaders will be available for you.
Additionally, during the show dates of CPhI Festival of Pharma, CordenPharma invites you to attend a LIVE WEBINAR: Your Injectable Roadmap for Combined Drug Product-Delivery Device Regulations & Evolving Capabilities in the New Normal on Tuesday, October 13th at 16:00 CEST / 10:00 EDT.
REGISTER HERE for this specially-designed webinar given by three key speakers representing the dynamic combined injectable drug product & delivery device industry from different angles:
Many new pharma development projects and lifecycle management opportunities are exploring the integration of medical devices with drug products as the industry seeks more convenient, user-focused drug delivery solutions. These emerging solutions often fall under the designation of ‘combination products’, where regulation, guidelines and applicable standards have evolved rapidly. Such a strong growth in this sector of the pharma industry has raised significant requirements on development, clinical supply, design transfer, risk management and commercial supply.
For many pharma companies, the investment, facilities, equipment, process controls and challenges associated with meeting the new corresponding manufacturing requirements are still not fully understood, and can be therefore quite burdensome. Identifying and engaging established, competent and experienced external providers such as a global CDMO is an excellent alternative.
During this webinar we will review the fundamentals of combined injectable delivery device – drug products.
Stay up to date with the latest thought leadership articles and news from CordenPharma.